Barclays PLC boosted its position in shares of Tyra Biosciences, Inc. (NASDAQ:TYRA – Free Report) by 14.5% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 43,070 shares of the company…